Why did IPA surge?

The stock price of IPA has experienced an increase of 26.92% on July 24, 2025. The surge in Immunoprecise Antibodies (IPA) stock price can be attributed to **New Findings in Predicting Drug Antibody Risks**. ImmunoPrecise Antibodies (IPA) has announced new findings from an expanded study highlighting the capabilities of its LENSai™ Immunogenicity Screening platform. This platform can predict Anti-Drug-Antibody (ADA) risk for therapeutic proteins before they reach animal or human trials. This development is significant as it has the potential to save billions in development costs by allowing drug developers to focus on safer molecules early in the process. |code|Ticker|Name|Date|Percentage Change|market_code| |---|---|---|---|---|---| |IPA|IPA.O|Immunoprecise|20250724|26.923076923076923|186| |code|Ticker|Name|Date|Post-Market Percentage Change|Pre-Market Percentage Change|market_code| |---|---|---|---|---|---|---| |IPA|IPA.O|Immunoprecise|20250724|3.0346320346320366|5.456043956043953|186| The announcement of these new findings is likely to have positively influenced investor sentiment, leading to an increase in the company's stock price. This is supported by the recent analyst rating of "Buy" with a $9.00 price target.